Patent · US Expired

Macrocyclic lactams and pharmaceutical use thereof

US7612055B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Yves Auberson · Allschwil, CH
Claudia Betschart · Basel, CH
Ralf Glatthar · Annaberg-Buchholz, DE
Kurt Laumen · Wuppertal, DE
Rainer Machauer · Glückstadt, DE
Marina Tintelnot-Blomley · Maulburg, DE
Thomas J. Troxler · Wahlen, CH
Siem Jacob Veenstra · Basel, CH

Key dates

Filing date	Nov 4, 2004
Grant date	Nov 3, 2009
Priority date	—
Expiry date	Dec 6, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to novel macrocyclic compounds of the formulawherein R1, R2, R3, U, V, W, X, Y, Z and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form or in acid addition salt form, to their preparation, to their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.